Swiss National Bank decreased its holdings in Teleflex Incorporated (NYSE:TFX - Free Report) by 4.5% during the 4th quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 133,100 shares of the medical technology company's stock after selling 6,200 shares during the quarter. Swiss National Bank owned 0.29% of Teleflex worth $23,689,000 at the end of the most recent quarter.
Other hedge funds have also added to or reduced their stakes in the company. HighTower Advisors LLC boosted its position in shares of Teleflex by 24.3% during the fourth quarter. HighTower Advisors LLC now owns 4,969 shares of the medical technology company's stock valued at $884,000 after buying an additional 971 shares during the last quarter. Cooke & Bieler LP lifted its stake in Teleflex by 22.1% during the 4th quarter. Cooke & Bieler LP now owns 1,078,557 shares of the medical technology company's stock valued at $191,962,000 after acquiring an additional 195,150 shares in the last quarter. Marathon Trading Investment Management LLC purchased a new position in Teleflex during the 4th quarter worth $1,211,000. Daiwa Securities Group Inc. grew its stake in shares of Teleflex by 3.4% in the 4th quarter. Daiwa Securities Group Inc. now owns 11,674 shares of the medical technology company's stock worth $2,077,000 after acquiring an additional 379 shares in the last quarter. Finally, Isthmus Partners LLC raised its holdings in shares of Teleflex by 7.3% in the fourth quarter. Isthmus Partners LLC now owns 1,535 shares of the medical technology company's stock valued at $273,000 after purchasing an additional 105 shares during the last quarter. Institutional investors and hedge funds own 95.62% of the company's stock.
Analyst Upgrades and Downgrades
TFX has been the topic of several analyst reports. Morgan Stanley cut their price target on shares of Teleflex from $275.00 to $191.00 and set an "overweight" rating on the stock in a report on Wednesday, March 5th. Needham & Company LLC restated a "hold" rating on shares of Teleflex in a research note on Wednesday, March 12th. Royal Bank of Canada downgraded Teleflex from an "outperform" rating to a "sector perform" rating and decreased their price target for the company from $220.00 to $155.00 in a research report on Friday, February 28th. Truist Financial cut their price objective on Teleflex from $200.00 to $149.00 and set a "hold" rating on the stock in a research report on Monday, March 3rd. Finally, Piper Sandler reaffirmed a "neutral" rating and set a $140.00 target price (down from $255.00) on shares of Teleflex in a research report on Friday, February 28th. One analyst has rated the stock with a sell rating, nine have assigned a hold rating and two have assigned a buy rating to the company. According to MarketBeat.com, Teleflex currently has a consensus rating of "Hold" and a consensus price target of $182.63.
Get Our Latest Stock Report on TFX
Teleflex Stock Performance
Shares of NYSE TFX traded up $2.34 during trading on Friday, reaching $141.77. 12,053,190 shares of the stock traded hands, compared to its average volume of 548,534. The company has a debt-to-equity ratio of 0.37, a current ratio of 2.42 and a quick ratio of 1.39. The stock has a market capitalization of $6.57 billion, a P/E ratio of 28.19, a price-to-earnings-growth ratio of 1.73 and a beta of 1.21. Teleflex Incorporated has a 52-week low of $128.55 and a 52-week high of $249.91. The company has a 50-day moving average of $163.83 and a 200-day moving average of $195.11.
Teleflex (NYSE:TFX - Get Free Report) last released its quarterly earnings data on Thursday, February 27th. The medical technology company reported $3.89 EPS for the quarter, beating the consensus estimate of $3.86 by $0.03. The business had revenue of $795.40 million for the quarter, compared to the consensus estimate of $813.24 million. Teleflex had a net margin of 7.85% and a return on equity of 14.19%. Analysts forecast that Teleflex Incorporated will post 13.98 EPS for the current fiscal year.
Teleflex Announces Dividend
The firm also recently disclosed a quarterly dividend, which was paid on Monday, March 17th. Investors of record on Friday, March 7th were paid a $0.34 dividend. The ex-dividend date of this dividend was Friday, March 7th. This represents a $1.36 dividend on an annualized basis and a yield of 0.96%. Teleflex's dividend payout ratio is 95.77%.
Teleflex Company Profile
(
Free Report)
Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. The company provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site.
See Also
Before you consider Teleflex, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Teleflex wasn't on the list.
While Teleflex currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Options trading isn’t just for the Wall Street elite; it’s an accessible strategy for anyone armed with the proper knowledge. Think of options as a strategic toolkit, with each tool designed for a specific financial task. Get this report to learn how options trading can help you use the market’s volatility to your advantage.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
